ROG Roche Holding AG

22.23USD31.80 CAD · TSX-1.79%Mkt Cap: 355.99B USDP/E: 23.91

Key Statistics

Company
Market Cap355.99B USD
Enterprise Value—
Revenue (TTM)—
Gross Profit55.43B USD
Net Income (TTM)15.28B USD
Revenue/Share—
Last Price22.23 USD
Fiscal Year End—
MR Quarter—
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - General
ISINCA77119A1030
Valuation
P/E (Trailing)23.91
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B3.64
EPS (TTM)—
EPS (Forward)—
52W Range
16.4092% of range22.75
52W High22.75 USD
52W Low16.40 USD
Profitability
Gross Margin73.73%
Oper. Margin—
EBITDA Margin—
Profit Margin20.33%
ROE38.10%
ROA12.79%
ROIC27.02%
ROCE25.41%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF22.37B USD
CapEx (TTM)6.86B USD
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Net Debt/FCF—
Balance Sheet
Debt/Equity0.98
Current Ratio—
Quick Ratio—
Book Value/Sh10.37 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate6.85 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.13.87B
Float—
Insiders—
Institutions—
Technical
SMA 5020.89 (+6.4%)
SMA 20019.21 (+15.7%)
Beta—
S&P 52W Chg—
Avg Vol (30d)3.21K
Avg Vol (10d)7.78K
Technical Indicators
RSI (14)56.7
MACD0.6337
MACD Signal0.6881
MACD Hist.-0.0544
BB Upper22.76 USD
BB Middle22.16 USD
BB Lower21.56 USD
BB Width5.43%
ATR (14)0.2717 USD
Vol Ratio (20d)0.14x

About Roche Holding (TSE: ROG)

›

Roche Holding (TSE: ROG) is listed on the Toronto Stock Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - General industry, part of the Healthcare sector.

The shares were at 31.80 CAD on 19 November 2026, up 43.9% over 52 weeks. Its 52-week range is 23.46 CAD to 32.54 CAD: the price is 2.3% below the high and 35.5% above the low.

At a market capitalisation of 509.25B CAD, it trades at 23.9 times trailing earnings. The median trailing P/E of its 17 largest Drug Manufacturers - General peers is 25.4, so ROG is valued in line with them.

Roche Holding reports return on equity of 38.1%.

Its Piotroski F-score is 7 out of 9, a strong reading of its financial health.